WeightWatchers stock rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...
WW surge after GLP-1 compounding announcement not justified after study, Barclays says
A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
clickondetroit.com20h
Low insurance coverage hampers access to weight-loss medications
In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...
Only 1 in 5 large companies' health plans cover new weight-loss meds for employees
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
What's Going With WeightWatchers Stock On Wednesday?
WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...
WeightWatchers' stock soars 60% premarket to extend prior-day gains
Shares of WW International Inc., known as WeightWatchers, soared 60% early Wednesday to extend their prior-day gains that came after the weight-management company announced the addition of compounded ...
WeightWatchers offering compounded version of Ozempic, despite concerns expressed by FDA
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
bovnews1d
WeightWatchers (WW) Surges in Premarket Trading: A Closer Look at Recent Developments
WeightWatchers recently announced the inclusion of compounded semaglutide into its suite of offerings. This new clinical weight management intervention aims to broaden access for eligible members who ...
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...